InnovaDerma Acquires Ergon Medical

Ergon Medical Ltd. the owner of the intellectual property rights of ProlongTM, the world's only medical device cleared by the U.S. Food & Drug Administration ("FDA") for premature ejaculation. Prolong is a Class II vibrating medical device as classified by the FDA and used as part of a climax control programme for males who suffer from premature ejaculation. It is designed to increase the time between arousal and ejaculation through the use of the training sessions using the stimulating vibratory effects of the device on the penis as part of the "Start-Stop" technique. Prolong offers an affordable, pain-free, one-off, or long-term treatment option with no side effects.